nodes	percent_of_prediction	percent_of_DWPC	metapath
Dopamine—SLC22A2—Cisplatin—esophageal cancer	0.108	0.55	CbGbCtD
Dopamine—CYP2C9—Capecitabine—esophageal cancer	0.059	0.299	CbGbCtD
Dopamine—CYP2C9—Cisplatin—esophageal cancer	0.0297	0.151	CbGbCtD
Dopamine—HTR7—vagus nerve—esophageal cancer	0.0176	0.144	CbGeAlD
Dopamine—Dobutamine—CA2—esophageal cancer	0.00594	0.402	CrCbGaD
Dopamine—DBH—digestive system—esophageal cancer	0.00544	0.0445	CbGeAlD
Dopamine—Masoprocol—CYP19A1—esophageal cancer	0.0046	0.311	CrCbGaD
Dopamine—HTR7—neck—esophageal cancer	0.00386	0.0316	CbGeAlD
Dopamine—COMT—bronchus—esophageal cancer	0.00372	0.0305	CbGeAlD
Dopamine—MAOA—neck—esophageal cancer	0.00369	0.0302	CbGeAlD
Dopamine—COMT—smooth muscle tissue—esophageal cancer	0.00364	0.0298	CbGeAlD
Dopamine—SLC22A2—digestive system—esophageal cancer	0.00358	0.0293	CbGeAlD
Dopamine—COMT—trachea—esophageal cancer	0.00334	0.0273	CbGeAlD
Dopamine—ADRB1—bronchus—esophageal cancer	0.00315	0.0258	CbGeAlD
Dopamine—DBH—lymph node—esophageal cancer	0.00311	0.0254	CbGeAlD
Dopamine—SLC22A3—smooth muscle tissue—esophageal cancer	0.00306	0.0251	CbGeAlD
Dopamine—MAOB—bronchus—esophageal cancer	0.0029	0.0237	CbGeAlD
Dopamine—COMT—digestive system—esophageal cancer	0.00288	0.0235	CbGeAlD
Dopamine—Mesalazine—PTGS1—esophageal cancer	0.0027	0.183	CrCbGaD
Dopamine—HTR7—epithelium—esophageal cancer	0.00262	0.0215	CbGeAlD
Dopamine—HTR7—smooth muscle tissue—esophageal cancer	0.00253	0.0207	CbGeAlD
Dopamine—MAOA—bronchus—esophageal cancer	0.00247	0.0202	CbGeAlD
Dopamine—COMT—lung—esophageal cancer	0.0024	0.0196	CbGeAlD
Dopamine—SLC6A4—digestive system—esophageal cancer	0.00235	0.0193	CbGeAlD
Dopamine—HTR7—trachea—esophageal cancer	0.00232	0.019	CbGeAlD
Dopamine—SLC22A5—bronchus—esophageal cancer	0.00228	0.0186	CbGeAlD
Dopamine—MAOB—digestive system—esophageal cancer	0.00224	0.0183	CbGeAlD
Dopamine—MAOA—trachea—esophageal cancer	0.00222	0.0182	CbGeAlD
Dopamine—SLC6A3—lung—esophageal cancer	0.00214	0.0175	CbGeAlD
Dopamine—SLC22A5—trachea—esophageal cancer	0.00204	0.0167	CbGeAlD
Dopamine—ADRB1—lung—esophageal cancer	0.00203	0.0166	CbGeAlD
Dopamine—SLC22A3—lung—esophageal cancer	0.00202	0.0165	CbGeAlD
Dopamine—HTR7—digestive system—esophageal cancer	0.002	0.0163	CbGeAlD
Dopamine—SLC6A4—lung—esophageal cancer	0.00197	0.0161	CbGeAlD
Dopamine—CYP2C19—digestive system—esophageal cancer	0.00195	0.016	CbGeAlD
Dopamine—MAOA—digestive system—esophageal cancer	0.00191	0.0156	CbGeAlD
Dopamine—MAOB—lung—esophageal cancer	0.00187	0.0153	CbGeAlD
Dopamine—SLC22A5—digestive system—esophageal cancer	0.00176	0.0144	CbGeAlD
Dopamine—SLC6A2—lung—esophageal cancer	0.00173	0.0142	CbGeAlD
Dopamine—HTR7—lung—esophageal cancer	0.00167	0.0136	CbGeAlD
Dopamine—COMT—lymph node—esophageal cancer	0.00164	0.0134	CbGeAlD
Dopamine—MAOA—lung—esophageal cancer	0.00159	0.013	CbGeAlD
Dopamine—CYP1A2—digestive system—esophageal cancer	0.00159	0.013	CbGeAlD
Dopamine—DRD2—lung—esophageal cancer	0.00158	0.0129	CbGeAlD
Dopamine—Mesalazine—PTGS2—esophageal cancer	0.00154	0.104	CrCbGaD
Dopamine—CYP2C9—digestive system—esophageal cancer	0.00151	0.0124	CbGeAlD
Dopamine—SLC22A5—lung—esophageal cancer	0.00147	0.012	CbGeAlD
Dopamine—SLC22A3—lymph node—esophageal cancer	0.00138	0.0113	CbGeAlD
Dopamine—CYP1A2—lung—esophageal cancer	0.00133	0.0109	CbGeAlD
Dopamine—MAOB—lymph node—esophageal cancer	0.00128	0.0105	CbGeAlD
Dopamine—SLC6A2—lymph node—esophageal cancer	0.00118	0.00968	CbGeAlD
Dopamine—CYP2D6—digestive system—esophageal cancer	0.00113	0.00928	CbGeAlD
Dopamine—MAOA—lymph node—esophageal cancer	0.00109	0.00892	CbGeAlD
Dopamine—SLC22A5—lymph node—esophageal cancer	0.001	0.00821	CbGeAlD
Dopamine—DRD5—Signaling by GPCR—EGFR—esophageal cancer	4.23e-05	6.35e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—SMAD4—esophageal cancer	4.22e-05	6.34e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—FBXW7—esophageal cancer	4.22e-05	6.34e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—ALDOB—esophageal cancer	4.21e-05	6.32e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—GNG7—esophageal cancer	4.19e-05	6.29e-05	CbGpPWpGaD
Dopamine—SLC22A3—Metabolism—NOS3—esophageal cancer	4.18e-05	6.27e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—TYMP—esophageal cancer	4.15e-05	6.23e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—GAPDH—esophageal cancer	4.09e-05	6.14e-05	CbGpPWpGaD
Dopamine—SLC22A1—Metabolism—ABCB1—esophageal cancer	4.08e-05	6.13e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—TGFBR2—esophageal cancer	4.06e-05	6.1e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—HIF1A—esophageal cancer	4.06e-05	6.1e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—GAPDH—esophageal cancer	4.05e-05	6.09e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—CRABP1—esophageal cancer	4.05e-05	6.09e-05	CbGpPWpGaD
Dopamine—DRD5—GPCR downstream signaling—PIK3CA—esophageal cancer	4.04e-05	6.07e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—CYP26A1—esophageal cancer	4.04e-05	6.06e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—CRABP1—esophageal cancer	4.02e-05	6.03e-05	CbGpPWpGaD
Dopamine—COMT—Metabolism—EP300—esophageal cancer	3.96e-05	5.95e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—ALOX15—esophageal cancer	3.93e-05	5.91e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—ALDH2—esophageal cancer	3.93e-05	5.9e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—HIF1A—esophageal cancer	3.89e-05	5.84e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—TGFBR2—esophageal cancer	3.89e-05	5.84e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—KDR—esophageal cancer	3.89e-05	5.84e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—GNG7—esophageal cancer	3.85e-05	5.79e-05	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—NOS3—esophageal cancer	3.85e-05	5.79e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—NOTCH2—esophageal cancer	3.85e-05	5.78e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—SMAD4—esophageal cancer	3.85e-05	5.78e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—GNG7—esophageal cancer	3.82e-05	5.74e-05	CbGpPWpGaD
Dopamine—SLC22A3—Metabolism—PTGS2—esophageal cancer	3.82e-05	5.74e-05	CbGpPWpGaD
Dopamine—MAOB—Metabolism—EP300—esophageal cancer	3.76e-05	5.64e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—GSTO1—esophageal cancer	3.75e-05	5.64e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—TPI1—esophageal cancer	3.75e-05	5.64e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—GSTT1—esophageal cancer	3.73e-05	5.61e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—KDR—esophageal cancer	3.72e-05	5.59e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—CYP2A6—esophageal cancer	3.69e-05	5.54e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—SMAD4—esophageal cancer	3.68e-05	5.53e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	3.68e-05	5.52e-05	CbGpPWpGaD
Dopamine—DRD5—Signaling by GPCR—PIK3CA—esophageal cancer	3.67e-05	5.51e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—NOTCH1—esophageal cancer	3.66e-05	5.5e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—ALDH2—esophageal cancer	3.61e-05	5.42e-05	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—ERBB2—esophageal cancer	3.61e-05	5.41e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—ALDOB—esophageal cancer	3.6e-05	5.4e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—ALDH2—esophageal cancer	3.58e-05	5.38e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—NOTCH1—esophageal cancer	3.5e-05	5.26e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—HIF1A—esophageal cancer	3.5e-05	5.26e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—PTGS1—esophageal cancer	3.5e-05	5.26e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—ENO1—esophageal cancer	3.5e-05	5.26e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—GAPDH—esophageal cancer	3.46e-05	5.2e-05	CbGpPWpGaD
Dopamine—MAOA—Metabolism—CREBBP—esophageal cancer	3.46e-05	5.2e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—HIF1A—esophageal cancer	3.45e-05	5.19e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—PSME2—esophageal cancer	3.45e-05	5.18e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—PSME1—esophageal cancer	3.45e-05	5.18e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—GSTT1—esophageal cancer	3.44e-05	5.16e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—CRABP1—esophageal cancer	3.43e-05	5.16e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—TGFBR2—esophageal cancer	3.41e-05	5.13e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—GSTT1—esophageal cancer	3.41e-05	5.11e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—CYP2A6—esophageal cancer	3.4e-05	5.1e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—CYP2A6—esophageal cancer	3.37e-05	5.06e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	3.35e-05	5.04e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—KDR—esophageal cancer	3.35e-05	5.03e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—CREBBP—esophageal cancer	3.32e-05	4.98e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—KDR—esophageal cancer	3.3e-05	4.96e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—GNG7—esophageal cancer	3.27e-05	4.9e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling by GPCR—EGFR—esophageal cancer	3.26e-05	4.9e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—SMAD4—esophageal cancer	3.23e-05	4.85e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—ENO1—esophageal cancer	3.22e-05	4.83e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—PTGS1—esophageal cancer	3.22e-05	4.83e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—PTGS1—esophageal cancer	3.19e-05	4.79e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—ENO1—esophageal cancer	3.19e-05	4.79e-05	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—CCND1—esophageal cancer	3.19e-05	4.78e-05	CbGpPWpGaD
Dopamine—SLC22A3—Metabolism—EP300—esophageal cancer	3.18e-05	4.77e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—CREBBP—esophageal cancer	3.18e-05	4.77e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—PSME2—esophageal cancer	3.17e-05	4.76e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—PSME1—esophageal cancer	3.17e-05	4.76e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—NOTCH1—esophageal cancer	3.15e-05	4.74e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—HIF1A—esophageal cancer	3.15e-05	4.73e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—PSME2—esophageal cancer	3.14e-05	4.72e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—PSME1—esophageal cancer	3.14e-05	4.72e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling by GPCR—EGFR—esophageal cancer	3.12e-05	4.69e-05	CbGpPWpGaD
Dopamine—HTR7—GPCR downstream signaling—PIK3CA—esophageal cancer	3.12e-05	4.68e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—NOTCH1—esophageal cancer	3.11e-05	4.67e-05	CbGpPWpGaD
Dopamine—MAOA—Metabolism—NOS3—esophageal cancer	3.1e-05	4.65e-05	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—CDKN1A—esophageal cancer	3.08e-05	4.63e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—ALDH2—esophageal cancer	3.06e-05	4.6e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	3.01e-05	4.52e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—HIF1A—esophageal cancer	3.01e-05	4.52e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—KDR—esophageal cancer	3.01e-05	4.52e-05	CbGpPWpGaD
Dopamine—DRD4—GPCR downstream signaling—PIK3CA—esophageal cancer	2.98e-05	4.48e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—CYP1B1—esophageal cancer	2.98e-05	4.47e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—NOS3—esophageal cancer	2.97e-05	4.46e-05	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—EP300—esophageal cancer	2.93e-05	4.4e-05	CbGpPWpGaD
Dopamine—COMT—Metabolism—PIK3CA—esophageal cancer	2.93e-05	4.4e-05	CbGpPWpGaD
Dopamine—SLC22A2—Metabolism—CREBBP—esophageal cancer	2.93e-05	4.39e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—GSTT1—esophageal cancer	2.91e-05	4.37e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—KDR—esophageal cancer	2.88e-05	4.32e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—CYP2A6—esophageal cancer	2.88e-05	4.32e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	2.87e-05	4.3e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—CREBBP—esophageal cancer	2.86e-05	4.3e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—NOS3—esophageal cancer	2.84e-05	4.27e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—NOTCH1—esophageal cancer	2.84e-05	4.26e-05	CbGpPWpGaD
Dopamine—MAOA—Metabolism—PTGS2—esophageal cancer	2.83e-05	4.26e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling by GPCR—PIK3CA—esophageal cancer	2.83e-05	4.25e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—CREBBP—esophageal cancer	2.82e-05	4.24e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling by GPCR—EGFR—esophageal cancer	2.81e-05	4.22e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—CYP19A1—esophageal cancer	2.8e-05	4.2e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—ERBB2—esophageal cancer	2.78e-05	4.17e-05	CbGpPWpGaD
Dopamine—MAOB—Metabolism—PIK3CA—esophageal cancer	2.78e-05	4.17e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling by GPCR—EGFR—esophageal cancer	2.77e-05	4.16e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	2.75e-05	4.12e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—CYP1B1—esophageal cancer	2.74e-05	4.11e-05	CbGpPWpGaD
Dopamine—SLC22A1—Metabolism—CREBBP—esophageal cancer	2.73e-05	4.1e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—PTGS1—esophageal cancer	2.73e-05	4.1e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—ENO1—esophageal cancer	2.73e-05	4.1e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—CYP1B1—esophageal cancer	2.71e-05	4.08e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—NOTCH1—esophageal cancer	2.71e-05	4.07e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling by GPCR—PIK3CA—esophageal cancer	2.71e-05	4.07e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—PSME2—esophageal cancer	2.69e-05	4.04e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—PSME1—esophageal cancer	2.69e-05	4.04e-05	CbGpPWpGaD
Dopamine—DRD1—GPCR downstream signaling—PIK3CA—esophageal cancer	2.69e-05	4.03e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—ERBB2—esophageal cancer	2.66e-05	4e-05	CbGpPWpGaD
Dopamine—DRD3—GPCR downstream signaling—PIK3CA—esophageal cancer	2.65e-05	3.98e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—HIF1A—esophageal cancer	2.64e-05	3.97e-05	CbGpPWpGaD
Dopamine—SLC22A2—Metabolism—NOS3—esophageal cancer	2.62e-05	3.93e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—CYP19A1—esophageal cancer	2.57e-05	3.87e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—CREBBP—esophageal cancer	2.57e-05	3.86e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—NOS3—esophageal cancer	2.56e-05	3.85e-05	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—MYC—esophageal cancer	2.55e-05	3.84e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—HMOX1—esophageal cancer	2.55e-05	3.83e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—CYP19A1—esophageal cancer	2.55e-05	3.83e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—KDR—esophageal cancer	2.53e-05	3.8e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling by GPCR—EGFR—esophageal cancer	2.53e-05	3.79e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—NOS3—esophageal cancer	2.53e-05	3.79e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	2.5e-05	3.76e-05	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—EGFR—esophageal cancer	2.5e-05	3.75e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—CREBBP—esophageal cancer	2.46e-05	3.69e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—CCND1—esophageal cancer	2.46e-05	3.69e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—ABCB1—esophageal cancer	2.45e-05	3.68e-05	CbGpPWpGaD
Dopamine—SLC22A1—Metabolism—NOS3—esophageal cancer	2.44e-05	3.67e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling by GPCR—PIK3CA—esophageal cancer	2.44e-05	3.66e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling by GPCR—EGFR—esophageal cancer	2.42e-05	3.63e-05	CbGpPWpGaD
Dopamine—ADRB1—GPCR downstream signaling—PIK3CA—esophageal cancer	2.41e-05	3.63e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling by GPCR—PIK3CA—esophageal cancer	2.41e-05	3.61e-05	CbGpPWpGaD
Dopamine—SLC22A2—Metabolism—PTGS2—esophageal cancer	2.4e-05	3.6e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—ERBB2—esophageal cancer	2.4e-05	3.6e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—NOTCH1—esophageal cancer	2.38e-05	3.58e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—CDKN1A—esophageal cancer	2.38e-05	3.57e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—ERBB2—esophageal cancer	2.36e-05	3.55e-05	CbGpPWpGaD
Dopamine—MAOA—Metabolism—EP300—esophageal cancer	2.36e-05	3.54e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—CCND1—esophageal cancer	2.35e-05	3.53e-05	CbGpPWpGaD
Dopamine—SLC22A3—Metabolism—PIK3CA—esophageal cancer	2.35e-05	3.53e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—HMOX1—esophageal cancer	2.35e-05	3.53e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	2.35e-05	3.52e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—HMOX1—esophageal cancer	2.33e-05	3.5e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—CYP1B1—esophageal cancer	2.32e-05	3.48e-05	CbGpPWpGaD
Dopamine—HTR1A—GPCR downstream signaling—PIK3CA—esophageal cancer	2.31e-05	3.47e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—NOS3—esophageal cancer	2.3e-05	3.46e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	2.28e-05	3.43e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—CDKN1A—esophageal cancer	2.27e-05	3.42e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—EP300—esophageal cancer	2.26e-05	3.39e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—ABCB1—esophageal cancer	2.25e-05	3.39e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—ABCB1—esophageal cancer	2.23e-05	3.36e-05	CbGpPWpGaD
Dopamine—SLC22A1—Metabolism—PTGS2—esophageal cancer	2.23e-05	3.35e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—NOS3—esophageal cancer	2.2e-05	3.31e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling by GPCR—PIK3CA—esophageal cancer	2.19e-05	3.29e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—CYP19A1—esophageal cancer	2.18e-05	3.27e-05	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—PIK3CA—esophageal cancer	2.17e-05	3.26e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—EP300—esophageal cancer	2.16e-05	3.25e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—CREBBP—esophageal cancer	2.16e-05	3.24e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—ERBB2—esophageal cancer	2.15e-05	3.23e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling by GPCR—EGFR—esophageal cancer	2.12e-05	3.19e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—CCND1—esophageal cancer	2.12e-05	3.18e-05	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—TP53—esophageal cancer	2.1e-05	3.15e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling by GPCR—PIK3CA—esophageal cancer	2.1e-05	3.15e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—CCND1—esophageal cancer	2.09e-05	3.14e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—ERBB2—esophageal cancer	2.06e-05	3.09e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—CDKN1A—esophageal cancer	2.05e-05	3.07e-05	CbGpPWpGaD
Dopamine—DRD2—GPCR downstream signaling—PIK3CA—esophageal cancer	2.03e-05	3.05e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—CDKN1A—esophageal cancer	2.02e-05	3.03e-05	CbGpPWpGaD
Dopamine—SLC22A2—Metabolism—EP300—esophageal cancer	1.99e-05	2.99e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—HMOX1—esophageal cancer	1.99e-05	2.99e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—MYC—esophageal cancer	1.97e-05	2.96e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	1.95e-05	2.93e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—EP300—esophageal cancer	1.95e-05	2.93e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—NOS3—esophageal cancer	1.93e-05	2.9e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—EGFR—esophageal cancer	1.93e-05	2.89e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—EP300—esophageal cancer	1.92e-05	2.89e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—ABCB1—esophageal cancer	1.91e-05	2.87e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—CCND1—esophageal cancer	1.9e-05	2.86e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—MYC—esophageal cancer	1.89e-05	2.83e-05	CbGpPWpGaD
Dopamine—SLC22A1—Metabolism—EP300—esophageal cancer	1.86e-05	2.79e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	1.85e-05	2.78e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—EGFR—esophageal cancer	1.84e-05	2.77e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling by GPCR—PIK3CA—esophageal cancer	1.84e-05	2.77e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—CDKN1A—esophageal cancer	1.84e-05	2.76e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—CCND1—esophageal cancer	1.82e-05	2.73e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—ERBB2—esophageal cancer	1.81e-05	2.72e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—CDKN1A—esophageal cancer	1.76e-05	2.64e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—EP300—esophageal cancer	1.75e-05	2.63e-05	CbGpPWpGaD
Dopamine—MAOA—Metabolism—PIK3CA—esophageal cancer	1.74e-05	2.62e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—MYC—esophageal cancer	1.7e-05	2.55e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	1.69e-05	2.54e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—EP300—esophageal cancer	1.68e-05	2.52e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—MYC—esophageal cancer	1.67e-05	2.52e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—PIK3CA—esophageal cancer	1.67e-05	2.51e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—EGFR—esophageal cancer	1.66e-05	2.49e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—EGFR—esophageal cancer	1.64e-05	2.46e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—CREBBP—esophageal cancer	1.64e-05	2.46e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—TP53—esophageal cancer	1.62e-05	2.43e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—PIK3CA—esophageal cancer	1.6e-05	2.4e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—CCND1—esophageal cancer	1.6e-05	2.4e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—TP53—esophageal cancer	1.55e-05	2.33e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—CDKN1A—esophageal cancer	1.55e-05	2.32e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—MYC—esophageal cancer	1.53e-05	2.29e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—CREBBP—esophageal cancer	1.51e-05	2.26e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—CREBBP—esophageal cancer	1.49e-05	2.24e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—EGFR—esophageal cancer	1.49e-05	2.24e-05	CbGpPWpGaD
Dopamine—SLC22A2—Metabolism—PIK3CA—esophageal cancer	1.47e-05	2.21e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—EP300—esophageal cancer	1.47e-05	2.21e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—NOS3—esophageal cancer	1.47e-05	2.2e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—MYC—esophageal cancer	1.46e-05	2.19e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	1.44e-05	2.17e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—PIK3CA—esophageal cancer	1.44e-05	2.16e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—EGFR—esophageal cancer	1.43e-05	2.14e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—PIK3CA—esophageal cancer	1.42e-05	2.14e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—TP53—esophageal cancer	1.39e-05	2.09e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—TP53—esophageal cancer	1.38e-05	2.07e-05	CbGpPWpGaD
Dopamine—SLC22A1—Metabolism—PIK3CA—esophageal cancer	1.37e-05	2.06e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—NOS3—esophageal cancer	1.35e-05	2.03e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—PTGS2—esophageal cancer	1.34e-05	2.01e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—NOS3—esophageal cancer	1.34e-05	2.01e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—PIK3CA—esophageal cancer	1.3e-05	1.95e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—MYC—esophageal cancer	1.28e-05	1.92e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—CREBBP—esophageal cancer	1.28e-05	1.92e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—EGFR—esophageal cancer	1.25e-05	1.88e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—TP53—esophageal cancer	1.25e-05	1.88e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—PIK3CA—esophageal cancer	1.24e-05	1.86e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—PTGS2—esophageal cancer	1.23e-05	1.85e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—PTGS2—esophageal cancer	1.22e-05	1.84e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—TP53—esophageal cancer	1.2e-05	1.8e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—NOS3—esophageal cancer	1.14e-05	1.72e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—EP300—esophageal cancer	1.12e-05	1.68e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—PIK3CA—esophageal cancer	1.09e-05	1.63e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—TP53—esophageal cancer	1.05e-05	1.58e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—PTGS2—esophageal cancer	1.05e-05	1.57e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—EP300—esophageal cancer	1.03e-05	1.54e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—EP300—esophageal cancer	1.02e-05	1.53e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—EP300—esophageal cancer	8.69e-06	1.31e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—PIK3CA—esophageal cancer	8.25e-06	1.24e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—PIK3CA—esophageal cancer	7.59e-06	1.14e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—PIK3CA—esophageal cancer	7.52e-06	1.13e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—PIK3CA—esophageal cancer	6.43e-06	9.66e-06	CbGpPWpGaD
